Show simple item record

dc.contributor.authorExecutive Board, 124
dc.date.accessioned2011-11-23T09:55:53Z
dc.date.available2011-11-23T09:55:53Z
dc.date.issued2009
dc.identifier.govdocEB124/14 Add.1
dc.identifier.urihttp://www.who.int/iris/handle/10665/2514
dc.descriptionExecutive Board 124th session, provisional agenda item 4.11en
dc.language.isoenen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Contaminationen
dc.subject.meshFinancial Managementen
dc.subject.meshFrauden
dc.titleReport on financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board or Health Assemblyen
dc.typeGoverning body documentsen
dc.subject.meshqualifiereconomicsen
who.relation.languageVersion10665/2604en
who.relation.languageVersion10665/3332en
who.relation.languageVersion10665/2886en
who.relation.languageVersion10665/3670en
who.relation.languageVersion10665/2932en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB124
    19-27 January 2009

Show simple item record